Title: E-cigarette, or vaping, product use-associated lung injury (EVALI) update from CDC

Category: Toxicology

Keywords: EVALI, e-cigarette, vaping, lung injury (PubMed Search)

Posted: 11/22/2019 by Hong Kim, MD

 

As of November 20, 2019:

2290 cases of e-cigarette, or vaping, product use-associated lung injury (EVALI) from 49 states (except Alaska), District of Columbia and 2 U.S. territories.

Analysis of 29 bronchoalveolar lavage (BAL) fluid samples from EVALI patients submitted to CDC from 10 states showed:

*** Vitamin E acetate appears to be associated with EVALI but the investigation is continuing.*** 

Some research has suggested that oral vitamin E use has potential beneficial effects (i.e. anti-inflammatory/antioxidant) in the lung (e.g. asthma and allergic lung disease), cardiovascular disease and prostate cancer (Cook-Mills JM et al. 2013; Jiang Q et al. 2001)

Common uses of vitamin E

There is limited to no data on pulmonary effect of vitamin E from inhalation in the scientific literature.

Stay tuned for additional updates from CDC.

References

  1. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html
  2. Cook-Mills J et al. Two vaces of vitmain E in the lung. Am J Respir Crit Care Med. 2013;188:279-284.
  3. Jiang Q et al. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001;74:714-722.